KALA BIO
KALA
26 hedge funds and large institutions have $24M invested in KALA BIO in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
99% more capital invested
Capital invested by funds: $12.1M → $24M (+$11.9M)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
18% more funds holding
Funds holding: 22 → 26 (+4)
0.58% more ownership
Funds ownership: 0.92% → 1.5% (+0.58%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.8M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$1.96M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$1.46M |
| 4 |
SOCM
SR One Capital Management
Wayne,
Pennsylvania
|
+$979K |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$765K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$540K |
| 2 |
Renaissance Technologies
New York
|
-$122K |
| 3 |
Millennium Management
New York
|
-$29.6K |
| 4 |
Two Sigma Investments
New York
|
-$13.2K |
| 5 |
Morgan Stanley
New York
|
-$315 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $257 | – | – | – |
|
27
Group One Trading
Chicago,
Illinois
| $153 | – | – | – |
|
|
CW
28
Curio Wealth
Annapolis,
Maryland
| $139 | – | – | – |
|
|
LIS
29
Legacy Investment Solutions
Meridian,
Idaho
| $111 | – | – | – |
|
|
LWMI
30
Legacy Wealth Management (Idaho)
Boise,
Idaho
| $111 | – | – | – |
|
|
SS
31
SBI Securities
Tokyo,
Japan
| $56 | – | – | – |
|
|
PA
32
Parallel Advisors
San Francisco,
California
| $7 | – | – | – |
|
|
33
Renaissance Technologies
New York
| – | -$122K | -429 | Closed |
|
34
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$114 | – | – |
|
KALA Hedge Fund Activity: Q4 2024 in Review
26 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2024, worth a combined $24M — up 99% from $12.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new KALA positions and 1 closed out — a net gain of 4 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $3.8M. The largest seller was ADAR1 Capital Management, cutting an estimated $540K.
- 26 institutional investors held KALA BIO (KALA) as of Q4 2024, up from 22 in Q3 2024.
- Funds reported $24M of KALA BIO stock for Q4 2024, up 99% quarter-over-quarter.
- 5 funds opened new KALA BIO positions in Q4 2024 and 1 closed out, a net change of +4 holders.
- The largest KALA BIO buyer in Q4 2024 was Cormorant Asset Management, an estimated $3.8M added.
- The largest KALA BIO seller in Q4 2024 was ADAR1 Capital Management, an estimated $540K sold.
Based on aggregated 13F filings for Q4 2024.